methylprednisolone has been researched along with quinacrine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Benveniste, J; Cazenave, JP; Mustard, JF | 1 |
| Murphy, TM; Peters-Golden, M; Sporn, PH | 1 |
| Mata, R; Muniain, MA; Pérez, JJ; Pozuelo, F; Rodríguez, MC; Rodríguez, MD; Romero, A | 1 |
| Canham, EM; Harada, RN; McMurtry, IF; Repine, JE; Shoemaker, SA; Tate, RM | 1 |
| Boros, M; Karácsony, G; Kaszaki, J; Nagy, S | 1 |
| Hara, A; Hirose, Y; Murashita, H; Oikawa, K; Sakai, S; Tabuchi, K | 1 |
| Danza, A; Ruiz-Irastorza, G; Ugarte, A | 1 |
1 review(s) available for methylprednisolone and quinacrine
| Article | Year |
|---|---|
Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.
Topics: Antimalarials; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisone; Quinacrine; Treatment Outcome | 2018 |
12 other study(ies) available for methylprednisolone and quinacrine
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs.
Topics: Animals; Arachidonic Acids; Blood Platelets; Cell Membrane; Chlorpromazine; Edetic Acid; Egtazic Acid; Fibrinogen; Humans; Imipramine; Lidocaine; Methylprednisolone; Platelet Aggregation; Prostaglandins; Quinacrine; Rabbits; Reserpine; Serotonin | 1979 |
Glucocorticoids fail to inhibit arachidonic acid metabolism stimulated by hydrogen peroxide in the alveolar macrophage.
Topics: Animals; Arachidonic Acids; Bronchoalveolar Lavage Fluid; Cells, Cultured; Eicosanoids; Female; Glucocorticoids; Hydrogen Peroxide; Macrophages; Methylprednisolone; Pulmonary Alveoli; Quinacrine; Rats; Rats, Inbred Strains; Zymosan | 1990 |
[Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)].
Topics: Agranulocytosis; Animals; Cell Aggregation; Complement System Proteins; Furans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neutropenia; Platelet Activating Factor; Quinacrine; Rabbits; Zymosan | 1988 |
Mepacrine but not methylprednisolone decreases acute edematous lung injury after injection of phorbol myristate acetate in rabbits.
Topics: Animals; Lung; Methylprednisolone; Neutrophils; Phorbols; Premedication; Pulmonary Edema; Quinacrine; Rabbits; Respiratory Distress Syndrome; Tetradecanoylphorbol Acetate | 1983 |
Reperfusion mucosal damage after complete intestinal ischemia in the dog: the effects of antioxidant and phospholipase A2 inhibitor therapy.
Topics: Allopurinol; Animals; Antioxidants; Dexamethasone; Dogs; Female; Ileum; Intestinal Mucosa; Ischemia; Male; Methylprednisolone; Phospholipases A; Phospholipases A2; Quinacrine; Quinolines; Reperfusion Injury | 1993 |
The effects of the glucocorticoid receptor antagonist RU486 and phospholipase A2 inhibitor quinacrine on acoustic injury of the mouse cochlea.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Auditory Threshold; Cell Death; Cochlear Diseases; Drug Interactions; Evoked Potentials, Auditory, Brain Stem; Female; Hair Cells, Auditory, Outer; Methylprednisolone; Mice; Neuroprotective Agents; Quinacrine | 2007 |